DBV Technologies (DBVT) Net Income Growth (1y) (2021 - 2026)
DBV Technologies (DBVT) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - | - |
| 10 | DBV Technologies | 5.92 Bn | 5.75 Bn | - | -20.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20.29% |
| Mar 31, 2026 | -75.65% |
| Dec 31, 2025 | -94.78% |
| Sep 30, 2025 | -8.94% |
| Jun 30, 2025 | -26.52% |
| Mar 31, 2025 | 0.90% |
| Dec 31, 2024 | -105.75% |
| Sep 30, 2024 | -81.90% |
| Jun 30, 2024 | -36.60% |
| Mar 31, 2024 | -32.99% |
| Dec 31, 2023 | 71.49% |
| Sep 30, 2023 | 3.19% |
| Jun 30, 2023 | -5.23% |
| Mar 31, 2023 | -23.08% |
| Dec 31, 2022 | -187.02% |
| Sep 30, 2022 | 28.07% |
| Jun 30, 2022 | 24.84% |
| Mar 31, 2022 | 43.27% |
| Dec 31, 2021 | 65.37% |
| Sep 30, 2021 | 22.36% |